Pieris Pharmaceu (PIRS) Stock Price, News & Analysis
Company Description
Pieris Pharmaceu (NASDAQ: PIRS) is classified in the research and development in biotechnology industry within the Pharmaceutical Preparations sector and carries a market capitalization of $18.0M, ranking #6,316 among all listed U.S. companies by market cap.
PIRS has gained 21.4% over the past year. Shares last traded at $13.60.
This page collects what Stock Titan holds for PIRS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Pieris Pharmaceu (PIRS) stock last closed at $13.60. Over the past 12 months, the stock has gained 21.4%. At a market capitalization of $18.0M, PIRS is classified as a micro-cap stock with approximately 1.3M shares outstanding.
PIRS Rankings
Latest News
Pieris Pharmaceu has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, stock split, clinical trial, conferences, earnings. View all PIRS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
PIRS Company Profile & Sector Positioning
Pieris Pharmaceu (PIRS) operates in the Research and Development in Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.